RE:RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break outRelated to Big Pharma ramping up M&A activity in the second half of 2023 .
June 08, 2023 - The Federal Trade Commission (FTC) is building out its deep dive into the pharmacy benefit management industry yet again. Group purchasing organization (GPOs) are also often sister companies to PBMs, which has similarly drawn ire from legislators.
Interest in reforms to the pharmacy benefit management market has grown alongside rising drug prices. Pharmaceutical companies have pointed the finger at PBMs as the culprit in price increases, and the lack of transparency in the industry lends credence to those claims to many policymakers.
https://www.fiercehealthcare.com/payers/ftc-adds-third-gpo-its-investigation-pharmacy-benefit-managers